Upgrade to SI Premium - Free Trial

FDA approves second OTC naloxone nasal spray, Rextovy

June 16, 2026 10:08 AM
The U.S. Food and Drug Administration has approved Rextovy, a 4 milligram naloxone hydrochloride nasal spray, for over-the-counter sale as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA